We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform

News   Mar 26, 2012

 
Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform
 
 
 

RELATED ARTICLES

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

Computational Models of the Human Lung: Potential for Personalized Medicine & Inhalation Toxicology

News

Combining high-performance computing, high-fidelity modeling, and high-resolution medical imaging, produces simulations that have the potential to contribute to new diagnostic tools and treatment options for respiratory disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE